The case for publishing 'negative' clinical trials

Pain

Volumn 146, Issue 3, 2009, Pages 225-226

  Rowbotham, Michael C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; EDITORIAL; FOOD AND DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; PUBLICATION;

CLINICAL TRIALS AS TOPIC; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 70350617935     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2009.09.026     Document Type: Editorial

References (12)

1. Bareket-Samish A., Denny M., Ruzicka B., Bogush M., Flynn K., Glinka K., McMahon-Wise B., Schiller S., Sjostedt P., and Matheson N. Good publication practice guidelines for medical communications agencies: a MedComm perspective. Curr Med Res Opin 25 (2009) 453-461
2. Barnes S.A., Mallinckrodt C.H., Lindborg S.R., and Carter M.K. The impact of missing data and how it is handled on the rate of false-positive results in drug development. Pharm Stat 7 (2008) 215-225
3. Dwan K., Gamble C., Williamson P.R., and Altman D.G. Reporting of clinical trials: a review of research funders' guidelines. Trials 9 (2008) 66
4. Galer B.S., Lee D., Ma T., Nagle B., and Schlagheck T.G. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Pain 115 (2005) 284-295
5. Hutton J.L., and Williamson P.R. Bias in meta-analysis due to outcome variable selection within studies. Appl Stat 49 (2000) 359-370
6. Moher D., Schulz K.F., and Altman D.G. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 357 (2001) 1191-1194
7. Nassir Ghaemi S., Shirzadi A.A., and Filkowski M. Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder. Medscape J Med 10 (2008) 211
8. The Outcome Reporting Bias in Trials (ORBIT) project. Available from: http://www.orbitstudy.org.uk/;. [accessed June 2009].
9. Thienel U., Neto W., Schwabe S.K., and Vijapurkar U. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand 110 (2004) 221-231
10. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., and Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358 (2008) 252-260
11. Wager E., Field E.A., and Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin 19 (2003) 149-154
12. World Medical Association: World Medical Association Declaration of Helsinki: ethical principles for research involving human subjects. Adopted by the 18th WMA, Helsinki, Finland, June, 1964. Amended by the 52nd WMA General Assembly, Edinburgh, Scotland, October, 2000. Available from: http://www.wma.net/e/policy/b3.htm; 2000. Ferney-Voltaire: World Medical Association [accessed June 2009].